Sanofi inks deal to help Saudi Arabia manufacture vaccines locally

In June, Sau­di Ara­bia’s Pub­lic In­vest­ment Fund es­tab­lished Lif­era, a con­tract de­vel­op­er and man­u­fac­tur­er in the phar­ma­ceu­ti­cal field, and now the com­pa­ny has se­cured a ma­jor client.

On Wednes­day, Lif­era and the Sau­di-based vac­cine man­u­fac­tur­er Arab Phar­ma­ceu­ti­cal Com­pa­ny, or Ara­bio, signed a mem­o­ran­dum of un­der­stand­ing with Sanofi to boost the lo­cal vac­cine pro­duc­tion with­in Sau­di Ara­bia.

Un­der the terms of the agree­ment, all three com­pa­nies will search for op­por­tu­ni­ties to col­lab­o­rate to form a lo­cal­iza­tion strat­e­gy for de­vel­op­ing and pro­duc­ing vac­cines.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN